Radioactive Iodine Therapy Does not Improve Cancer-specific Survival in Hürthle Cell Carcinoma of the Thyroid.

Xiaofei WangXun ZhengJingqiang ZhuZhihui LiTao Wei

Published in: The Journal of clinical endocrinology and metabolism (2022)

RAI has no statistically significant influence on the CSS in HCC patients. This information may aid in decision-making for RAI therapy in these patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
decision making
peritoneal dialysis
prognostic factors
stem cells
healthcare
magnetic resonance imaging
computed tomography
patient reported outcomes
papillary thyroid
bone marrow